Spots Global Cancer Trial Database for Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation
Official Title: A Prospective Development Study Evaluating Focal Therapy Using Irreversible Electroporation (Nanoknife®) in Men With Localised Prostate Cancer
Study ID: NCT01726894
Conditions
Interventions
Study Description
Brief Summary: To determine the adverse events and genito-urinary side-effect profile of focal therapy to treat localised low to intermediate risk prostate cancer using irreversible electroporation (Nanoknife™).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University College London Hospitals, London, , United Kingdom
Contact Details
Name: Hashim U Ahmed, PhD
Affiliation: UCLH
Role: PRINCIPAL_INVESTIGATOR
Name: Mark Emberton, Professor
Affiliation: UCLH
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
